We are analyzing https://link.springer.com/article/10.1007/s10549-011-1620-1.

Title:
The prognostic significance of B lymphocytes in invasive carcinoma of the breast | Breast Cancer Research and Treatment
Description:
Although the favourable role of T lymphocyte populations in different tumour types is established, that of B cells is still a matter of debate and needs further clarification. The presence of tumour-infiltrating B cells may represent an antibody response against breast tumour antigens. We used immunohistochemistry to investigate the density and localisation of B lymphocytes infiltrating 1470 breast tumours and to identify any prognostic significance and relationship to various clinicopathological factors. Higher numbers of CD20+ cells were found in the stroma away from the carcinoma (mean 12 cells) compared with either intratumoural or adjacent stromal compartments (mean 1 cell). The majority of tumours showed a diffuse pattern of B cells rather than aggregates. There was a positive correlation between higher numbers of total CD20+ B cells and higher tumour grade (r s = 0.20, P < 0.001), ER and PgR negativity (P < 0.001), and basal phenotype (P < 0.001) subclass. In univariate survival analysis, higher total number of infiltrating CD20+ cells, irrespective of location, was associated with significantly better BCSS (P = 0.037) and longer DFI (P = 0.001). In multivariate analysis, total CD20+ B cell count (HR = 0.75, 95% CI = 0.58–0.96 for BCSS and HR = 0.72, 95% CI = 0.58–0.89, for DFI), tumour size, nodal stage, grade, vascular invasion, HER-2 status, and total CD8+ T cell count were independently associated with outcome. This suggests that humoral immunity, in addition to the cell mediated immunity, may be important in breast cancer. This should be considered in breast cancer immunotherapy and vaccine strategies.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

breast, cancer, google, scholar, article, pubmed, cas, cells, prognostic, carcinoma, lymphocytes, lee, cell, ellis, paish, res, analysis, green, immunol, human, tumour, infiltrating, clin, nottingham, mahmoud, access, pathol, expression, privacy, cookies, content, research, significance, invasive, macmillan, factors, outcome, tumorinfiltrating, rakha, histopathology, university, publish, search, study, june, role, lymphocyte, relationship, higher, total,

Topics {✒️}

abd el-rehim dm outcome-based cut-point optimization b-cell infiltration correlates pd-l1 + tumor-infiltrating lymphocytes month download article/chapter antigen-driven clonal proliferation rna-transfected cd40-activated friend virus-induced leukemia tumour-infiltrating lymphocytes correlate triple-negative breast cancer node-negative breast cancer human tumor-infiltrating lymphocytes antigen-driven oligoclonal expansion cell-mediated immune mechanisms lymphocyte-specific antigen el-rehim da full article pdf related subjects privacy choices/manage cookies b-ware tumour infiltrating lymphocytes human breast cancer tumor antigen targets metastatic ovarian carcinoma primary breast cancer breast tumour antigens wolchok jd apoptotic cancer cells cell mediated immunity infiltrating cd20+ cells medullary breast cancer human breast carcinoma el-sheikh se human breast cancers stat soc series female breast cancer infiltrating ductal carcinoma cell-cycle progression higher tumour grade breast carcinomas—correlation beta-catenin expression circulating anti-tumor foxp3+ infiltrating cells early epithelial carcinogenesis article mahmoud breast cancer immunotherapy inflammatory breast cancer matched circulating lymphocytes stromal lymphocyte infiltration european economic area

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The prognostic significance of B lymphocytes in invasive carcinoma of the breast
         description:Although the favourable role of T lymphocyte populations in different tumour types is established, that of B cells is still a matter of debate and needs further clarification. The presence of tumour-infiltrating B cells may represent an antibody response against breast tumour antigens. We used immunohistochemistry to investigate the density and localisation of B lymphocytes infiltrating 1470 breast tumours and to identify any prognostic significance and relationship to various clinicopathological factors. Higher numbers of CD20+ cells were found in the stroma away from the carcinoma (mean 12 cells) compared with either intratumoural or adjacent stromal compartments (mean 1 cell). The majority of tumours showed a diffuse pattern of B cells rather than aggregates. There was a positive correlation between higher numbers of total CD20+ B cells and higher tumour grade (r s = 0.20, P < 0.001), ER and PgR negativity (P < 0.001), and basal phenotype (P < 0.001) subclass. In univariate survival analysis, higher total number of infiltrating CD20+ cells, irrespective of location, was associated with significantly better BCSS (P = 0.037) and longer DFI (P = 0.001). In multivariate analysis, total CD20+ B cell count (HR = 0.75, 95% CI = 0.58–0.96 for BCSS and HR = 0.72, 95% CI = 0.58–0.89, for DFI), tumour size, nodal stage, grade, vascular invasion, HER-2 status, and total CD8+ T cell count were independently associated with outcome. This suggests that humoral immunity, in addition to the cell mediated immunity, may be important in breast cancer. This should be considered in breast cancer immunotherapy and vaccine strategies.
         datePublished:2011-06-14T00:00:00Z
         dateModified:2011-06-14T00:00:00Z
         pageStart:545
         pageEnd:553
         sameAs:https://doi.org/10.1007/s10549-011-1620-1
         keywords:
            CD20
            Immunohistochemistry
            Breast cancer
            B lymphocytes
            Humoral immunity
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig4_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:132
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:S. M. A. Mahmoud
               affiliation:
                     name:University of Nottingham, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
                     name:Mansoura University
                     address:
                        name:Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. H. S. Lee
               affiliation:
                     name:Nottingham University Hospitals NHS Trust
                     address:
                        name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. C. Paish
               affiliation:
                     name:Nottingham University Hospitals NHS Trust
                     address:
                        name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. D. Macmillan
               affiliation:
                     name:Nottingham University Hospitals NHS Trust
                     address:
                        name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. O. Ellis
               affiliation:
                     name:University of Nottingham, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
                     name:Nottingham University Hospitals NHS Trust
                     address:
                        name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. R. Green
               affiliation:
                     name:University of Nottingham, Queen’s Medical Centre
                     address:
                        name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The prognostic significance of B lymphocytes in invasive carcinoma of the breast
      description:Although the favourable role of T lymphocyte populations in different tumour types is established, that of B cells is still a matter of debate and needs further clarification. The presence of tumour-infiltrating B cells may represent an antibody response against breast tumour antigens. We used immunohistochemistry to investigate the density and localisation of B lymphocytes infiltrating 1470 breast tumours and to identify any prognostic significance and relationship to various clinicopathological factors. Higher numbers of CD20+ cells were found in the stroma away from the carcinoma (mean 12 cells) compared with either intratumoural or adjacent stromal compartments (mean 1 cell). The majority of tumours showed a diffuse pattern of B cells rather than aggregates. There was a positive correlation between higher numbers of total CD20+ B cells and higher tumour grade (r s = 0.20, P < 0.001), ER and PgR negativity (P < 0.001), and basal phenotype (P < 0.001) subclass. In univariate survival analysis, higher total number of infiltrating CD20+ cells, irrespective of location, was associated with significantly better BCSS (P = 0.037) and longer DFI (P = 0.001). In multivariate analysis, total CD20+ B cell count (HR = 0.75, 95% CI = 0.58–0.96 for BCSS and HR = 0.72, 95% CI = 0.58–0.89, for DFI), tumour size, nodal stage, grade, vascular invasion, HER-2 status, and total CD8+ T cell count were independently associated with outcome. This suggests that humoral immunity, in addition to the cell mediated immunity, may be important in breast cancer. This should be considered in breast cancer immunotherapy and vaccine strategies.
      datePublished:2011-06-14T00:00:00Z
      dateModified:2011-06-14T00:00:00Z
      pageStart:545
      pageEnd:553
      sameAs:https://doi.org/10.1007/s10549-011-1620-1
      keywords:
         CD20
         Immunohistochemistry
         Breast cancer
         B lymphocytes
         Humoral immunity
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1620-1/MediaObjects/10549_2011_1620_Fig4_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:132
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:S. M. A. Mahmoud
            affiliation:
                  name:University of Nottingham, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
                  name:Mansoura University
                  address:
                     name:Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. H. S. Lee
            affiliation:
                  name:Nottingham University Hospitals NHS Trust
                  address:
                     name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. C. Paish
            affiliation:
                  name:Nottingham University Hospitals NHS Trust
                  address:
                     name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. D. Macmillan
            affiliation:
                  name:Nottingham University Hospitals NHS Trust
                  address:
                     name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. O. Ellis
            affiliation:
                  name:University of Nottingham, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
                  name:Nottingham University Hospitals NHS Trust
                  address:
                     name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. R. Green
            affiliation:
                  name:University of Nottingham, Queen’s Medical Centre
                  address:
                     name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:132
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Nottingham, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:Mansoura University
      address:
         name:Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
         type:PostalAddress
      name:Nottingham University Hospitals NHS Trust
      address:
         name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS Trust
      address:
         name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS Trust
      address:
         name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
      name:Nottingham University Hospitals NHS Trust
      address:
         name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
         type:PostalAddress
      name:University of Nottingham, Queen’s Medical Centre
      address:
         name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:S. M. A. Mahmoud
      affiliation:
            name:University of Nottingham, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
            name:Mansoura University
            address:
               name:Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
               type:PostalAddress
            type:Organization
      name:A. H. S. Lee
      affiliation:
            name:Nottingham University Hospitals NHS Trust
            address:
               name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:E. C. Paish
      affiliation:
            name:Nottingham University Hospitals NHS Trust
            address:
               name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:R. D. Macmillan
      affiliation:
            name:Nottingham University Hospitals NHS Trust
            address:
               name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:I. O. Ellis
      affiliation:
            name:University of Nottingham, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
            name:Nottingham University Hospitals NHS Trust
            address:
               name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
               type:PostalAddress
            type:Organization
      name:A. R. Green
      affiliation:
            name:University of Nottingham, Queen’s Medical Centre
            address:
               name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
      name:Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
      name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
      name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
      name:The Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
      name:Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK
      name:Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(171)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.33s.

LINK . SPRINGER . COM {}